FDA: safety and efficacy of childrens cold medicine: why not Risperdal and Abilify?

I wrote about this before and it's back in the news again.

When the FDA pulled OTC cold medicines from the shelves,the concern was parents giving too much of the cold medicine. Now the revision is in discussion that could remove cold medicines for kids from the market.

The FDA questions regarding safety and efficacy, whether or not the cold medicines worked at all, and a group of pediatricians petitioned the FDA noting a lack of evidence "that they work and mounting evidence they can cause hallucinations, seizures, trouble breathing, heart problems and other complications including, occasionally, deaths."

AGAIN I ask the question:(and have been asking since March 2007)

Why are we not seeing this type of vigorous investigation into the safety and efficacy of antipsychotics that are being prescribed for children often under age 10?

There is no long term evidence that antipsychotics that carry a black box warning for diabetes are safe for children. Why OTC cold medicines gain so much attention from the FDA and pediatricians and antipsychotics don't --blows my mind.

Risperdal and Abilify have been approved by the FDA for use in children at age 10, and the danger in those drugs are far worse than the cold medicines. This is an outrageous and dangerous practice in my opinion, that the FDA seems to not understand how powerful antipsychotics are--compare Seroquel (Rebecca Riley died at age 4 with Seroquel in her system) to Dimetapp and wonder what is so wrong with this world.

I never thought I would see the day cough medicines were under review for safety and efficacy use in kids and antipsychotics are approved, without evidence of safety or long term results.

I think the FDA needs to review how they intend on keeping children safe from pharmaceutical injury.